Pfizer Inc. et al v. Dexcel Pharma Technologies Limited
| Pfizer Inc., FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Wyeth LLC and The Scripps Research Institute |
| Dexcel Pharma Technologies Limited |
| 1:2023cv00879 |
| August 10, 2023 |
| US District Court for the District of Delaware |
| Gregory B Williams |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on October 6, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 13
ORAL ORDER: IT IS HEREBY ORDERED that, not later than thirty (30) days from the date of this Order, the parties shall meet and confer and file a joint proposed Scheduling Order in this action consistent with the applicable form Scheduling Order of Judge Williams, which is posted at http://www/ded/uscourts.gov (See Chambers, Judge Williams, Forms), along with a cover letter requesting the Court to enter the joint proposed Scheduling Order (if there are no disputes or other issues concerning scheduling that the Court needs to address) or to schedule the Scheduling Conference. If there are disputes or other issues the Court needs to address in the joint proposed Scheduling Order, in the cover letter, the parties shall direct the Court to the paragraph numbers in the joint proposed Scheduling Order in which those appear. ORDERED by Judge Gregory B. Williams on 10/6/23. (ntl)
|
| Filing 12 ANSWER to #1 Complaint, by Dexcel Pharma Technologies Limited.(Gaza, Anne) |
| Pro Hac Vice Attorneys Alexander V. Alfano, Dennies Varughese, Pharm.D., Gaby L. Longsworth, Ph.D. for Dexcel Pharma Technologies Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) |
|
SO ORDERED, re #11 MOTION for Pro Hac Vice Appearance of Attorney Dennies Varughese, Pharm.D., Gaby L. Longsworth, Ph.D., and Alex Alfano filed by Dexcel Pharma Technologies Limited. Signed by Judge Gregory B. Williams on 9/6/23. (ntl)
|
| Filing 11 MOTION for Pro Hac Vice Appearance of Attorney Dennies Varughese, Pharm.D., Gaby L. Longsworth, Ph.D., and Alex Alfano - filed by Dexcel Pharma Technologies Limited. (Gaza, Anne) |
| Filing 10 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Dexcel PT Israel Limited for Dexcel Pharma Technologies Limited filed by Dexcel Pharma Technologies Limited. (Gaza, Anne) |
|
SO ORDERED, re #9 STIPULATION TO EXTEND TIME to move against, answer, or otherwise respond to Plaintiffs' Complaint to October 5, 2023 filed by Dexcel Pharma Technologies Limited. Signed by Judge Gregory B. Williams on 9/5/23. (ntl)
|
| Filing 9 STIPULATION TO EXTEND TIME to move against, answer, or otherwise respond to Plaintiffs' Complaint to October 5, 2023 - filed by Dexcel Pharma Technologies Limited. (Gaza, Anne) |
|
SO ORDERED, re #8 MOTION for Pro Hac Vice Appearance of Attorney Thomas H.L. Selby, Stanley E. Fisher, and Seth R. Bowers filed by Wyeth LLC, PF PRISM IMB B.V., FoldRx Pharmaceuticals, LLC, Pfizer Inc., The Scripps Research Institute. Signed by Judge Gregory B. Williams on 8/17/23. (ntl)
|
| Filing 8 MOTION for Pro Hac Vice Appearance of Attorney Thomas H.L. Selby, Stanley E. Fisher, and Seth R. Bowers - filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC. (Dellinger, Megan) |
| Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (rjb) |
| Filing 7 SUMMONS Returned Executed by Pfizer Inc., FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Wyeth LLC, The Scripps Research Institute.Dexcel Pharma Technologies Limited served on 8/14/2023, answer due 9/5/2023. (Dellinger, Megan) |
| Filing 6 Summons Issued as to Dexcel Pharma Technologies Limited. (mkr) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc. for FoldRx Pharmaceuticals, LLC, PF PRISM IMB. B.V., Pfizer Inc., The Scripps Research Institute, and Wyeth LLC filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB. B.V., Pfizer Inc., and The Scripps Research Institute, Wyeth LLC. (mkr) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,214,695 B2; 7,214,696 B2; 9,770,441 B2. (mkr) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: On or about June 27, 2023. Date of Expiration of Patent: U.S. Patent No. 7,214,695 expires on April 27, 2024. U.S. Patent No. 7,214,696 expires on December 19, 2023. U.S. Patent No. 9,770,441 expires on August 31, 2035.Thirty Month Stay Deadline: November 3, 2026. (mkr) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mkr) |
| Filing 1 COMPLAINT filed against Dexcel Pharma Technologies Limited (Filing fee $ 402, receipt number ADEDC-4199065.) - filed by Pfizer Inc., FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Wyeth LLC, and The Scripps Research Institute. (Attachments: #1 Exhibit A-C, #2 Civil Cover Sheet)(mkr) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
